|
Volumn 313, Issue 4, 2001, Pages 683-694
|
Hepatitis C virus NS3 NTPase/helicase: Different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step
|
Author keywords
Antiviral agents; HCV; Helicase; Hepatitis; Kinetics
|
Indexed keywords
2',3' DIDEHYDROTHYMIDINE TRIPHOSPHATE;
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ADENOSINE TRIPHOSPHATE;
ANTIVIRUS AGENT;
DEOXYADENOSINE TRIPHOSPHATE;
DEOXYNUCLEOSIDE TRIPHOSPHATE;
DIDEOXYNUCLEOSIDE TRIPHOSPHATE DERIVATIVE;
HELICASE;
NS3 NUCLEOSIDE TRIPHOSPHATASE;
NUCLEOSIDE ANALOG;
NUCLEOSIDE TRIPHOSPHATASE;
NUCLEOSIDE TRIPHOSPHATE;
NUCLEOTIDE;
UNCLASSIFIED DRUG;
VIRUS PROTEIN;
ARTICLE;
DRUG MECHANISM;
DRUG TARGETING;
ENZYME ACTIVITY;
ENZYME KINETICS;
ENZYME MECHANISM;
HEPATITIS C VIRUS;
HYDROLYSIS;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN TARGETING;
REACTION ANALYSIS;
STEADY STATE;
STEREOCHEMISTRY;
|
EID: 0035798412
PISSN: 00222836
EISSN: None
Source Type: Journal
DOI: 10.1006/jmbi.2001.5088 Document Type: Article |
Times cited : (22)
|
References (37)
|